Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Cardiology

How Does SPCD Affect the Heart and Cause Arrhythmias?

At a Glance

Systemic Primary Carnitine Deficiency (SPCD) deprives the heart of energy, causing severe muscle weakness (dilated cardiomyopathy) and dangerous electrical rhythms like Short QT syndrome. Daily, high-dose L-carnitine therapy can prevent and often completely reverse these life-threatening cardiac complications.

Systemic Primary Carnitine Deficiency (SPCD) affects the heart by depriving the heart muscle cells of their primary source of energy, leading to significant weakness and electrical instability [1][2]. Without enough carnitine to help convert fats into energy, the heart struggles to pump effectively and is prone to life-threatening rhythm changes [3][4]. However, these severe cardiac complications can be prevented, and existing damage can often be completely reversed, with consistent, high-dose L-carnitine therapy [5][6].

Why the Heart Needs Carnitine

To understand how SPCD affects the heart, it helps to know how the heart gets its energy. The heart is a continuously working muscle that relies almost entirely on fats for fuel [3]. To use fat for energy, the heart’s cells must transport fat molecules into the mitochondria, the energy-producing factories inside the cells [2].

Carnitine acts as the essential “shuttle” that moves these fat molecules into the mitochondria [2]. In SPCD, a genetic mutation causes a malfunctioning transporter protein (called OCTN2), leading to extremely low levels of carnitine in the body [7]. Without the carnitine shuttle, fats cannot be burned for energy, leading to a profound energy crisis in the heart muscle [1][3].

Cardiac Complications of SPCD

Dilated Cardiomyopathy

The lack of energy in the heart muscle frequently leads to dilated cardiomyopathy [3][8]. This is a condition where the heart’s main pumping chamber (the left ventricle) becomes enlarged, stretched, and severely weakened [4].
Because the heart cannot pump blood efficiently, fluid may build up in the lungs and body, causing symptoms of heart failure [8]. In some individuals, SPCD can also cause a related condition known as left ventricular noncompaction, where the heart muscle appears spongy rather than smooth and solid [8].

Arrhythmias and Short QT Syndrome

In addition to muscle weakness, the energy failure in SPCD disrupts the heart’s electrical system, which controls the heartbeat [9]. A notable electrical abnormality linked to SPCD is Short QT Syndrome (SQTS) [10][9].

The QT interval is a measurement taken on an electrocardiogram (EKG) that represents the time it takes for the heart’s electrical system to recharge between beats. In Short QT syndrome, this recharge time is abnormally brief [10]. This electrical instability can trigger chaotic, dangerous heart rhythms (arrhythmias) [9][11].

Risk of Sudden Cardiac Death

When left untreated, the combination of a weakened heart muscle and dangerous electrical rhythms puts individuals with SPCD at a high risk for sudden cardiac death [11][12]. This risk is particularly severe in young adults and females (often exacerbated by the severe metabolic stress of pregnancy or undiagnosed status) [12]. Acute cardiac events can also be triggered by sudden metabolic stressors like prolonged fasting or severe illness [12][13].

The Impact of L-Carnitine Therapy

While the cardiac effects of untreated SPCD are severe, the condition is highly treatable [5]. The primary treatment is daily, high-dose prescription L-carnitine, which is typically taken orally as a liquid or multiple pills spaced throughout the day [14][15].

  • Reversing Heart Damage: High-dose, prescription L-carnitine supplementation restores the heart’s ability to produce energy [6][5]. In many cases, dilated cardiomyopathy can be completely reversed with timely treatment, sometimes with noticeable improvements in heart function occurring within days [6][5].
  • Fixing Electrical Signals: L-carnitine therapy is also effective at normalizing the heart’s electrical recharge time, reversing Short QT syndrome [10].
  • Preventing Sudden Cardiac Death: Consistent daily use of L-carnitine prevents the heart from returning to an energy-deprived state, drastically reducing the risk of sudden cardiac death and long-term complications [9][12].

Daily Management and Emergency Protocols

Medication Adherence and Fasting

Because stopping treatment or routinely missing doses over time can lead to life-threatening complications, strict adherence to daily supplementation is critical [14][16]. However, accidentally taking a single dose a few hours late does not usually cause an immediate crisis.
In addition to medication, patients must avoid prolonged fasting [17]. For adults, this usually means not skipping meals and ensuring you eat regularly throughout the day to prevent your body from relying on fat stores for energy [13].

Sick Day Protocols

If you contract a stomach bug, start vomiting, or are otherwise unable to keep your oral L-carnitine down, this is considered a medical emergency [18]. During illness, your body is under stress and needs extra energy; without carnitine, your heart is at severe risk [13]. You must seek immediate care (often at an emergency room) to receive intravenous (IV) glucose and IV carnitine until you recover [6]. It is highly recommended to ask your metabolic specialist or cardiologist for an “emergency letter” outlining your condition and specific IV protocols to hand to emergency room staff.

Monitoring Your Heart Health

Your medical team will likely monitor your heart health using non-invasive tools such as:

  • Echocardiograms (Echo): An ultrasound of the heart to ensure the muscle is pumping strongly and is not enlarged [19][20].
  • Electrocardiograms (EKG/ECG): A tracing of the heart’s electrical activity to check the QT interval and ensure there are no dangerous arrhythmias [19][9].
  • Blood Tests: Regular checks of free carnitine levels to ensure your prescribed dosage is adequately meeting your heart’s energy demands [18][16].

Common questions in this guide

Why does SPCD cause heart failure and cardiomyopathy?
The heart relies heavily on fats for fuel. In SPCD, a lack of carnitine prevents fat from entering the heart cells' energy factories. Without this energy, the heart muscle becomes severely weakened, enlarged, and struggles to pump blood efficiently.
Can L-carnitine therapy reverse heart damage from SPCD?
Yes, high-dose prescription L-carnitine restores the heart's ability to produce energy. With consistent treatment, it can completely reverse dilated cardiomyopathy and normalize dangerous electrical rhythms, drastically reducing the risk of sudden cardiac death.
What should I do if I have SPCD and get a stomach bug?
Being unable to keep oral L-carnitine down during an illness is a life-threatening medical emergency. You must go to the emergency room immediately to receive intravenous (IV) glucose and IV carnitine to protect your heart from severe energy failure.
How often should my heart be monitored with SPCD?
Your medical team will monitor your heart using non-invasive tests like echocardiograms to check pumping strength and EKGs to monitor electrical activity. You should ask your cardiologist or metabolic specialist exactly how often you need these evaluations.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific instructions should be in my 'emergency letter' for the ER if I become ill and cannot keep my L-carnitine down?
  2. 2.How frequently should I have an echocardiogram and EKG to monitor my heart function and QT interval?
  3. 3.Are my current carnitine levels adequate to protect my heart, or do we need to adjust my L-carnitine dosage?
  4. 4.What are my safe limits for fasting, and do I need to wake up during the night for a snack?
  5. 5.Is my current heart function completely normal, or are there signs of dilated cardiomyopathy or left ventricular noncompaction that we need to monitor?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Molecular investigation in Chinese patients with primary carnitine deficiency.

    Zhang Y, Li H, Liu J, et al.

    Molecular genetics & genomic medicine 2019; (7(9)):e901 doi:10.1002/mgg3.901.

    PMID: 31364285
  2. 2

    Acylcarnitines in Cancer Metabolism: Mechanistic Insights and Stratification Potential.

    Lee HP, Oh J, Lee N, et al.

    Cancers 2026; (18(4)) doi:10.3390/cancers18040713.

    PMID: 41749966
  3. 3

    A case of atypical systemic primary carnitine deficiency in Saudi Arabia.

    Alghamdi A, Almalki H, Shawli A, et al.

    Pediatric reports 2018; (10(2)):7705 doi:10.4081/pr.2018.7705.

    PMID: 30069296
  4. 4

    A novel pathogenic variant in the carnitine transporter gene, SLC22A5, in association with metabolic carnitine deficiency and cardiomyopathy features.

    Jolfayi AG, Naderi N, Ghasemi S, et al.

    BMC cardiovascular disorders 2024; (24(1)):1 doi:10.1186/s12872-023-03676-z.

    PMID: 38166572
  5. 5

    Primary carnitine deficiency - diagnosis after heart transplantation: better late than never!

    Grünert SC, Tucci S, Schumann A, et al.

    Orphanet journal of rare diseases 2020; (15(1)):87 doi:10.1186/s13023-020-01371-2.

    PMID: 32276632
  6. 6

    Primary Carnitine Deficiency: A Rare, Reversible Metabolic Cardiomyopathy.

    Tomlinson S, Atherton J, Prasad S

    Case reports in cardiology 2018; (2018()):3232105 doi:10.1155/2018/3232105.

    PMID: 30302293
  7. 7

    Structural basis of sodium ion-dependent carnitine transport by OCTN2.

    Davies JS, Zeng YC, Briot C, et al.

    Nature communications 2025; (17(1)):181 doi:10.1038/s41467-025-66867-6.

    PMID: 41318751
  8. 8

    Left ventricular noncompaction in primary systemic carnitine deficiency: A rare association.

    Bhattacharya D, Sasikumar D, Kurup H, Krishnamoorthy KM

    Annals of pediatric cardiology 2021; (14(4)):521-523 doi:10.4103/apc.APC_152_20.

    PMID: 35527759
  9. 9

    Systemic primary carnitine deficiency induces severe arrhythmia due to shortening of QT interval.

    Lodewyckx P, Issa J, Gaschignard M, et al.

    Molecular genetics and metabolism 2023; (140(4)):107733 doi:10.1016/j.ymgme.2023.107733.

    PMID: 37979236
  10. 10

    Left ventricular noncompaction cardiomyopathy and short QT syndrome due to primary carnitine deficiency.

    Hanington OP, Armstrong C, Pierre G, et al.

    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2023; (28(6)):e13077 doi:10.1111/anec.13077.

    PMID: 37658577
  11. 11

    Increased risk of sudden death in untreated primary carnitine deficiency.

    Rasmussen J, Dunø M, Lund AM, et al.

    Journal of inherited metabolic disease 2020; (43(2)):290-296 doi:10.1002/jimd.12158.

    PMID: 31373028
  12. 12

    Molecular Autopsy Implicates Primary Carnitine Deficiency in Sudden Unexplained Death and Reversible Short QT Syndrome.

    Gélinas R, Leach E, Horvath G, Laksman Z

    The Canadian journal of cardiology 2019; (35(9)):1256.e1-1256.e2 doi:10.1016/j.cjca.2019.05.014.

    PMID: 31472821
  13. 13

    A Rare Case Report of Hypoketotic Hypoglycemia Induced Seizures Due to Secondary Carnitine Deficiency in a 44-year-old Female.

    Bangolo A, Tesoro N, Onyeka S, et al.

    Journal of community hospital internal medicine perspectives 2024; (14(3)):68-71 doi:10.55729/2000-9666.1279.

    PMID: 39036584
  14. 14

    Patients with primary carnitine deficiency treated with L-carnitine are alive and doing well-A 10-year follow-up in the Faroe Islands.

    Abrahamsen RK, Lund AM, Rasmussen J

    JIMD reports 2023; (64(6)):453-459 doi:10.1002/jmd2.12383.

    PMID: 37927485
  15. 15

    First Case Report of Primary Carnitine Deficiency Manifested as Intellectual Disability and Autism Spectrum Disorder.

    Guevara-Campos J, González-Guevara L, Guevara-González J, Cauli O

    Brain sciences 2019; (9(6)) doi:10.3390/brainsci9060137.

    PMID: 31200524
  16. 16

    A report of a pedigree with compound heterozygous mutations in the SLC22A5 gene.

    Zhou Y, Liu Y, Shen Y, et al.

    Frontiers in pediatrics 2023; (11()):985720 doi:10.3389/fped.2023.985720.

    PMID: 37351314
  17. 17

    Primary carnitine deficiency with severe acute hepatitis following rotavirus gastroenteritis.

    Ishige M, Fuchigami T, Furukawa M, et al.

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2019; (25(11)):913-916 doi:10.1016/j.jiac.2019.04.020.

    PMID: 31189503
  18. 18

    Primary carnitine deficiency is a life-long disease.

    Crefcoeur LL, Melles MC, Bruning TA, et al.

    JIMD reports 2022; (63(6)):524-528 doi:10.1002/jmd2.12319.

    PMID: 36341172
  19. 19

    Gene spectrum and clinical traits of 10 patients with primary carnitine deficiency.

    Chen Y, Lin Q, Zeng Y, et al.

    Molecular genetics & genomic medicine 2021; (9(2)):e1583 doi:10.1002/mgg3.1583.

    PMID: 33560599
  20. 20

    Analysis of genetic mutation distribution and metabolic characteristics in patients with primary carnitine deficiency from the Ganzhou area, China.

    Tu X, Zhang F, Chen J, Xie C

    Clinica chimica acta; international journal of clinical chemistry 2026; (584()):120873 doi:10.1016/j.cca.2026.120873.

    PMID: 41620002

This page explains the cardiac complications of SPCD for educational purposes only. It does not replace professional medical advice. Always consult your cardiologist or metabolic specialist regarding your specific treatment plan and emergency protocols.

Get notified when new evidence is published on Systemic primary carnitine deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.